Legend Biotech has recently emerged as a significant market player, drawing attention in the biotech industry.
This comes alongside new guidance issued for gene therapy developers, which may influence the sector's dynamics.
Additionally, there are reports of Eli Lilly's acquisition of kidney drug assets, further shaping the landscape for biotech companies.